Cutler Group LP Olema Pharmaceuticals, Inc. Transaction History

Cutler Group LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$2.72 - $5.88 $544 - $1,176	-200 Reduced 14.29%	1,200 $3,000
Q1 2022 Apr 14, 2022	SELL	$3.89 - $9.43 $21,395 - $51,865	-5,500 Reduced 79.71%	1,400 $5,000
Q4 2021 Jan 18, 2022	BUY	$8.75 - $30.71 $60,375 - $211,899	6,900 New	6,900 $64,000

145

58.3M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $248M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.